Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1756-1762
Published online before print May 13, 2004, doi: 10.1161/01.STR.0000130423.50191.9f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/7/1756    most recent
01.STR.0000130423.50191.9fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapral, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapral, M. K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Choosing a Doctor or Health Care Service
*Stroke
Related Collections
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrow Acute Stroke Syndromes
Right arrow Primary and Secondary Stroke Prevention
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Neuroprotectors
Right arrow Thrombolysis
Right arrow Other Stroke Treatment - Medical

(Stroke. 2004;35:1756.)
© 2004 American Heart Association, Inc.


Original Contributions

Stroke Care Delivery in Institutions Participating in the Registry of the Canadian Stroke Network

Moira K. Kapral, MD, MSc; Andreas Laupacis, MD, MSc; Stephen J. Phillips, MD; Frank L. Silver, MD; Michael D. Hill, MD, MSc; Jiming Fang, PhD; Janice Richards, RN Jack V. Tu, MD, PhD for the Investigators of the Registry of the Canadian Stroke Network

From the Institute for Clinical Evaluative Sciences (M.K.K., A.L., J.F., J.R., J.V.T.), Toronto, Ontario, Canada; the Division of General Internal Medicine and Clinical Epidemiology and Women’s Health Program (M.K.K), University Health Network, Toronto, Ontario, Canada; the Clinical Epidemiology and Health Care Research Program and Division of General Internal Medicine (A.L., J.V.T.), Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada; the Division of Neurology (F.L.S.), University Health Network, Toronto, Ontario, Canada; the Department of Medicine (M.K.K., A.L., F.L.S., J.V.T.), University of Toronto, Toronto, Ontario, Canada; the Department of Public Health Sciences (M.K.K., A.L., J.V.T.), University of Toronto, Toronto, Ontario, Canada; the Division of Neurology (S.J.P.), Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada; and the Departments of Clinical Neurosciences, Medicine, and Community Health Sciences (M.D.H.), University of Calgary, Calgary, Alberta, Canada.

Correspondence to Dr Moira K. Kapral, Toronto General Hospital, 200 Elizabeth St, ENG-246, Toronto, Ontario, Canada M5G 2C4. E-mail moira.kapral{at}uhn.on.ca

Background and Purpose— Guidelines and performance indicators have been established for acute stroke care. However, little is known about the process of stroke care delivery in Canada.

Methods— The Registry of the Canadian Stroke Network (RCSN) captured detailed clinical data on patients with stroke and transient ischemic attack seen at 21 acute care institutions across Canada. Data from phase 1 of the RCSN (June 2001 to February 2002) were used to determine the use of evidence-based acute stroke care interventions in participating institutions.

Results— Overall, 4439 patients were seen during the study time frame and 1701 (38%) consented to full data collection. Thirty-one percent received care on a stroke unit or from a mobile stroke team. Among patients with ischemic stroke, 7% received thrombolysis, 80% underwent carotid imaging, 89% received antithrombotic agents, and 54% of those with atrial fibrillation received warfarin. There were significant intersite variations in the delivery of all of these interventions except for the use of antithrombotic agents, and these persisted after adjustment for age, sex, stroke type, and other comorbid conditions.

Conclusions— Patients in institutions participating in the RCSN received high-quality stroke care based on a number of performance measures. However, gaps exist in the provision of other elements of stroke care, particularly organized inpatient stroke care and warfarin for atrial fibrillation. Future research should explore explanations for these findings and focus on solutions to deficiencies in care.


Key Words: stroke • quality of health care




This article has been cited by other articles:


Home page
BMJHome page
J. M Wardlaw, P. A G Sandercock, and V. Murray
Should more patients with acute ischaemic stroke receive thrombolytic treatment?
BMJ, November 11, 2009; 339(nov11_1): b4584 - b4584.
[Full Text]


Home page
StrokeHome page
G. Saposnik, M. K. Kapral, S. B. Coutts, J. Fang, A. M. Demchuk, M. D. Hill, and on behalf of the Investigators of the Registry of
Do All Age Groups Benefit From Organized Inpatient Stroke Care?
Stroke, October 1, 2009; 40(10): 3321 - 3327.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Indredavik
Stroke Unit Care Is Beneficial Both for the Patient and for the Health Service and Should Be Widely Implemented
Stroke, January 1, 2009; 40(1): 1 - 2.
[Full Text] [PDF]


Home page
StrokeHome page
M. F. Rafay, A.-M. Pontigon, J. Chiang, M. Adams, D. A. Jarvis, F. Silver, D. MacGregor, and G. A. deVeber
Delay to Diagnosis in Acute Pediatric Arterial Ischemic Stroke
Stroke, January 1, 2009; 40(1): 58 - 64.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. Bayley MD, P. Lindsay BScN PhD, C. Hellings BScH, E. Woodbury BCom MHA, S. Phillips MBBS, and on behalf of the Canadian Stroke Strategy (a joint
Balancing evidence and opinion in stroke care: the 2008 best practice recommendations
Can. Med. Assoc. J., December 2, 2008; 179(12): 1247 - 1249.
[Full Text] [PDF]


Home page
StrokeHome page
G. Saposnik, J. Fang, M. O'Donnell, V. Hachinski, M. K. Kapral, M. D. Hill, and on behalf of the Investigators of the Registry of
Escalating Levels of Access to In-Hospital Care and Stroke Mortality
Stroke, September 1, 2008; 39(9): 2522 - 2530.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Saposnik, M. D. Hill, M. O'Donnell, J. Fang, V. Hachinski, M. K. Kapral, and on behalf of the investigators of the Registry of
Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke
Stroke, August 1, 2008; 39(8): 2318 - 2324.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
P. Lindsay RN PhD, M. Bayley MD, A. McDonald BScPT, I. D. Graham PhD, G. Warner PhD, and S. Phillips MBBS
Toward a more effective approach to stroke: Canadian Best Practice Recommendations for Stroke Care
Can. Med. Assoc. J., May 20, 2008; 178(11): 1418 - 1425.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. M. Hakim
Vascular Disease: The Tsunami of Health Care
Stroke, December 1, 2007; 38(12): 3296 - 3301.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. R. Yip and B. M. Demaerschalk
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Stroke, June 1, 2007; 38(6): 1952 - 1955.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. U. Heuschmann, M. K. Biegler, O. Busse, S. Elsner, A. Grau, U. Hasenbein, P. Hermanek, R. W.C. Janzen, P. L. Kolominsky-Rabas, K. Kraywinkel, et al.
Development and Implementation of Evidence-Based Indicators for Measuring Quality of Acute Stroke Care: The Quality Indicator Board of the German Stroke Registers Study Group (ADSR)
Stroke, October 1, 2006; 37(10): 2573 - 2551.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. J.M. Scholte op Reimer, D. W.J. Dippel, C. L. Franke, R. J. v. Oostenbrugge, G. de Jong, S. Hoeks, and M. L. Simoons
Quality of Hospital and Outpatient Care After Stroke or Transient Ischemic Attack: Insights From a Stroke Survey in The Netherlands
Stroke, July 1, 2006; 37(7): 1844 - 1849.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Niewada, M. Skowronska, D. Ryglewicz, B. Kaminski, A. Czlonkowska, and on behalf of the Polish National Stroke Prevention
Acute Ischemic Stroke Care and Outcome in Centers Participating in the Polish National Stroke Prevention and Treatment Registry
Stroke, July 1, 2006; 37(7): 1837 - 1843.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Z. Deng, M. J. Reeves, B. S. Jacobs, G. L. Birbeck, R. U. Kothari, S. L. Hickenbottom, A. J. Mullard, S. Wehner, K. Maddox, A. Majid, et al.
IV tissue plasminogen activator use in acute stroke: Experience from a statewide registry
Neurology, February 14, 2006; 66(3): 306 - 312.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Norrving and R. J. Adams
Organized Stroke Care
Stroke, February 1, 2006; 37(2): 326 - 328.
[Full Text] [PDF]


Home page
StrokeHome page
B. Norrving
Editorial Comment--Organized Stroke Care: The Core of Effective Stroke Care Provision
Stroke, July 1, 2005; 36(7): 1616 - 1618.
[Full Text] [PDF]


Home page
StrokeHome page
The Paul Coverdell Prototype Registries Writing Gr
Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry
Stroke, June 1, 2005; 36(6): 1232 - 1240.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. K. Kapral, J. Fang, M. D. Hill, F. Silver, J. Richards, C. Jaigobin, A. M. Cheung, and for the Investigators of the Registry of the Canad
Sex Differences in Stroke Care and Outcomes: Results From the Registry of the Canadian Stroke Network
Stroke, April 1, 2005; 36(4): 809 - 814.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. P. Lindsay, M. K. Kapral, D. Gladstone, R. Holloway, J. V. Tu, A. Laupacis, and J. M. Grimshaw
The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care
Can. Med. Assoc. J., February 1, 2005; 172(3): 363 - 365.
[Full Text] [PDF]